{"title":"Role of Artificial Intelligence in Colonoscopy: A Literature Review of the Past, Present, and Future Directions","authors":"Saam Dilmaghani, Nayantara Coelho-Prabhu","doi":"10.1016/j.tige.2023.03.002","DOIUrl":null,"url":null,"abstract":"<div><p><span><span>Colonoscopy remains one of the most common procedures performed by gastroenterologists and is critical for early detection and management of precursors to colorectal cancer (CRC). Although CRC remains one of the deadliest </span>malignancies, earlier detection of precancerous polyps is directly associated with increased patient survival. As such, quality metrics for colonoscopy, such as polyp detection and mucosal visualization, are key parameters that are directly tied to patient outcomes. Over the past 2 decades, artificial intelligence and machine learning (AI/ML) tools have been tested and developed to augment colonoscopy performance and in 2021 resulted in the first-ever FDA-approved computer-aided detection (CADe) tool. This narrative review begins by reviewing the evidence behind the use of CADe that led to FDA approval. Next, the review discusses the current evidence and technological approaches for computer-aided diagnosis for optical in situ histopathological differentiation of </span>colorectal polyps<span><span><span>, including narrow-band imaging, blue light imaging, and endocytoscopy. Studies are ongoing to develop systems to predict the depth of submucosal invasion and to assess endoscopic disease activity among patients with inflammatory bowel disease. The applications of AI/ML to quality improvement are explored, including real-time assessment of </span>bowel preparation<span>, detection of cecal intubation, and automated polyp reporting and surveillance recommendations using natural language processing. Despite initial cost concerns, models have suggested that CADe systems could result in long-term cost savings and are generally accepted by patients and gastroenterologists. There is some reservation in adopting computer-aided diagnosis systems among gastroenterologists due to medico-legal concerns. Future directions for AI/ML in colonoscopy include </span></span>health system improvements, such as automating note writing, optimizing procedural scheduling, and predicting sedation needs.</span></p></div>","PeriodicalId":1,"journal":{"name":"Accounts of Chemical Research","volume":null,"pages":null},"PeriodicalIF":16.4000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Accounts of Chemical Research","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2590030723000260","RegionNum":1,"RegionCategory":"化学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CHEMISTRY, MULTIDISCIPLINARY","Score":null,"Total":0}
引用次数: 0
Abstract
Colonoscopy remains one of the most common procedures performed by gastroenterologists and is critical for early detection and management of precursors to colorectal cancer (CRC). Although CRC remains one of the deadliest malignancies, earlier detection of precancerous polyps is directly associated with increased patient survival. As such, quality metrics for colonoscopy, such as polyp detection and mucosal visualization, are key parameters that are directly tied to patient outcomes. Over the past 2 decades, artificial intelligence and machine learning (AI/ML) tools have been tested and developed to augment colonoscopy performance and in 2021 resulted in the first-ever FDA-approved computer-aided detection (CADe) tool. This narrative review begins by reviewing the evidence behind the use of CADe that led to FDA approval. Next, the review discusses the current evidence and technological approaches for computer-aided diagnosis for optical in situ histopathological differentiation of colorectal polyps, including narrow-band imaging, blue light imaging, and endocytoscopy. Studies are ongoing to develop systems to predict the depth of submucosal invasion and to assess endoscopic disease activity among patients with inflammatory bowel disease. The applications of AI/ML to quality improvement are explored, including real-time assessment of bowel preparation, detection of cecal intubation, and automated polyp reporting and surveillance recommendations using natural language processing. Despite initial cost concerns, models have suggested that CADe systems could result in long-term cost savings and are generally accepted by patients and gastroenterologists. There is some reservation in adopting computer-aided diagnosis systems among gastroenterologists due to medico-legal concerns. Future directions for AI/ML in colonoscopy include health system improvements, such as automating note writing, optimizing procedural scheduling, and predicting sedation needs.
期刊介绍:
Accounts of Chemical Research presents short, concise and critical articles offering easy-to-read overviews of basic research and applications in all areas of chemistry and biochemistry. These short reviews focus on research from the author’s own laboratory and are designed to teach the reader about a research project. In addition, Accounts of Chemical Research publishes commentaries that give an informed opinion on a current research problem. Special Issues online are devoted to a single topic of unusual activity and significance.
Accounts of Chemical Research replaces the traditional article abstract with an article "Conspectus." These entries synopsize the research affording the reader a closer look at the content and significance of an article. Through this provision of a more detailed description of the article contents, the Conspectus enhances the article's discoverability by search engines and the exposure for the research.